Michael D. Lockshin, MD assumed the editorship of Arthritis & Rheumatism on July 1, 2005. He succeeds Dr. David S. Pisetsky, for a five-year term.1
Dr. Lockshin is the Director of the Barbara Volcker Center for Women and Rheumatic Disease and Co-Director of the Mary Kirkland Center for Lupus Research at the Hospital for Special Surgery, and Professor of Medicine and Obstetrics-Gynecology at Joan and Sanford I. Weill Medical College of Cornell University in New York. He received his AB and MD degrees from Harvard University and his clinical training at the Second (Cornell) Medical Division Bellevue Hospital and Memorial Sloan-Kettering Hospital in New York, followed by a rheumatology fellowship at Columbia-Presbyterian Medical Center. As an Epidemic Intelligence Service officer for the Communicable Disease Center of the US Public Health Service, Dr. Lockshin was Assistant Professor of Epidemiology at the University of Pittsburgh School of Public Health, working on the health problems of coal miners. In 1970, he joined the Hospital for Special Surgery and Cornell University Medical College, where he became Professor of Medicine and Attending Physician. He moved to the National Institutes of Health in 1989, serving there as Extramural Director and then Acting Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. He then was senior advisor to the Director of the Clinical Center, NIH, before returning to the Hospital for Special Surgery in 1997.
A renowned investigator in the field of rheumatology, Dr. Lockshin's research interests have focused on systemic lupus erythematosus, the antiphospholipid antibody syndrome, and vasculitis. He coauthored the first reports on hepatitis B–associated polyarteritis nodosa, early reports on twins with lupus, studies on neurologic lupus including its treatment and the development of cognitive dysfunction, pregnancy and lupus, atherosclerosis and lupus, and many reports on the antiphospholipid antibody syndrome. His most recent interests have been on the sex distribution of disease.
Dr. Lockshin chaired the American Board of Internal Medicine Committee on Rheumatology and has served on many committees of the Arthritis Foundation and the American College of Rheumatology. He chaired the Arthritis Foundation Professional Education Committee and the ACR Audiovisual Aids Committee that produced the first Clinical Slide Collection. He was the first chairman of the ACR Committee on Rheumatologic Practice and was Second Vice President of the ACR in 1984–5. Dr. Lockshin was named a Master of the ACR in 2003. He has served on editorial boards of Arthritis & Rheumatism, Journal of Rheumatology, Lupus, American Journal of Reproductive Immunology, and other journals. He convened the first International Conference on Pregnancy and Rheumatic Disease and the first Conference on Gender, Biology, and Human Disease. He is the author of more than 230 scientific papers and textbook chapters and a book on health policy, Guarded Prognosis. He is a member of the Institute of Medicine Committee on Understanding the Biology of Sex and Gender Differences, its Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, its Health Sciences Policy Board, and its Committee on (NIH) Centers of Excellence Programs.
Some of Dr. Lockshin's stated goals for his editorship of Arthritis & Rheumatism include instituting means by which the journal can better accommodate the needs of both clinicians and researchers, increasing the visibility of the field of rheumatology to the public, and guiding the journal's integration into the electronic world. Along with his impressive team of Associate Editors, he has assembled a group of distinguished Co-Editors—Drs. Steven Abramson, Jill Buyon, Daniel Clauw, Mary Goldring, Joshua Jacobs, Alisa Koch, Nancy Lane, James O'Dell, Stephen Paget, Richard Pope, and Jane Salmon—to work with him to accomplish these goals. Under Dr. Lockshin's leadership, the American College of Rheumatology can look forward to our journal's maintaining and improving upon its already high standard of excellence.